Back to News
Market Impact: 0.2
Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal
Source: benzinga.com
Market Technicals & FlowsHealthcare & Biotech
Foghorn Therapeutics shares traded lower Thursday as volume surged to 9.158 million shares, roughly 24.3x its 377,206-share average, indicating unusually elevated trading activity. The article provides no stated catalyst, price decline magnitude, or fundamental update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
FHTX-0.35
More News
- Stifel cuts Foghorn Therapeutics stock price target on pipeline shift
- Dow Falls Over 200 Points; Micron Earnings Top Views
- Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
- US borrowing costs hit 24-year high as global bond sell-off intensifies
- These charts show how volatile the last quarter was for stocks and bonds
- Investors Are Driving Government Bond Yields Higher